Skip to content

INVIVO THERAPEUTICS HOLDINGS CORP.: 10-Q filed 2012-11-13

What INVIVO THERAPEUTICS HOLDINGS CORP. reported in its quarterly report filed 2012-11-13 (fiscal Q3 2012): 31 published measures, 105 facts as tagged in accession 0001193125-12-467498.

This filing

Form
10-Q (quarterly report)
Filed
2012-11-13
Fiscal period
fiscal Q3 2012
Accession
0001193125-12-467498 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All INVIVO THERAPEUTICS HOLDINGS CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-09-3018,488,156USD
At 2011-12-315,702,238USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-09-3012,999,194USD
At 2011-12-3136,861,932USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-09-305,488,962USD
At 2011-12-31-31,159,694USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-09-3015,549,609USD
At 2011-12-314,363,712USD
At 2011-09-303,686,929USD
At 2010-12-318,964,194USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-07-01 to 2012-09-308,028,915USD92
2012-01-01 to 2012-09-3013,379,619USD274
2005-11-29 to 2012-09-30-34,437,195USD2498
2011-07-01 to 2011-09-303,067,049USD92
2011-01-01 to 2011-09-30418,921USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-09-30-6,320,644USD274
2005-11-29 to 2012-09-30-20,538,917USD2498
2011-01-01 to 2011-09-30-5,146,408USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-01-01 to 2012-09-301,709,496USD274
2005-11-29 to 2012-09-302,340,204USD2498
2011-01-01 to 2011-09-30241,995USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-09-3019,216,037USD274
2005-11-29 to 2012-09-3038,428,730USD2498
2011-01-01 to 2011-09-30111,138USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-09-30-1,709,496USD274
2005-11-29 to 2012-09-30-2,340,204USD2498
2011-01-01 to 2011-09-30-241,995USD273

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2012-07-01 to 2012-09-3065,109,037shares92
2012-01-01 to 2012-09-3062,357,300shares274
2005-11-29 to 2012-09-3034,226,324shares2498
2011-07-01 to 2011-09-3051,889,111shares92
2011-01-01 to 2011-09-3051,743,138shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2012-07-01 to 2012-09-3074,157,957shares92
2012-01-01 to 2012-09-3071,734,784shares274
2005-11-29 to 2012-09-3034,226,324shares2498
2011-07-01 to 2011-09-3054,269,856shares92
2011-01-01 to 2011-09-3054,198,981shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2012-07-01 to 2012-09-300.12USD/shares92
2012-01-01 to 2012-09-300.21USD/shares274
2005-11-29 to 2012-09-30-1.01USD/shares2498
2011-07-01 to 2011-09-300.06USD/shares92
2011-01-01 to 2011-09-300.01USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2012-07-01 to 2012-09-300.11USD/shares92
2012-01-01 to 2012-09-300.19USD/shares274
2005-11-29 to 2012-09-30-1.01USD/shares2498
2011-07-01 to 2011-09-300.06USD/shares92
2011-01-01 to 2011-09-300.01USD/shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-09-302,024,524USD
At 2011-12-31520,482USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-01-01 to 2012-09-30823,617USD274
2005-11-29 to 2012-09-302,623,969USD2498
2011-01-01 to 2011-09-30622,141USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-2,840,901USD92
2012-01-01 to 2012-09-30-8,056,729USD274
2005-11-29 to 2012-09-30-25,192,100USD2498
2011-07-01 to 2011-09-30-2,213,320USD92
2011-01-01 to 2011-09-30-6,141,303USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-09-3016,310,618USD
At 2011-12-315,015,617USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-07-01 to 2012-09-3012,454USD92
2012-01-01 to 2012-09-3028,147USD274
2005-11-29 to 2012-09-301,094,478USD2498
2011-01-01 to 2011-09-307,150USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-09-3012,848,325USD
At 2011-12-3136,740,096USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-09-301,141,267USD
At 2011-12-31567,195USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-07-01 to 2012-09-302,840,901USD92
2012-01-01 to 2012-09-308,056,729USD274
2005-11-29 to 2012-09-3025,192,100USD2498
2011-07-01 to 2011-09-302,213,320USD92
2011-01-01 to 2011-09-306,141,303USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-07-01 to 2012-09-301,374,852USD92
2012-01-01 to 2012-09-303,622,800USD274
2005-11-29 to 2012-09-3012,506,634USD2498
2011-07-01 to 2011-09-301,016,865USD92
2011-01-01 to 2011-09-303,045,426USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-09-3065,635,400shares
At 2011-12-3153,760,471shares

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2012-09-30153,014USD
At 2011-12-31166,139USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2012-09-30761,939USD
At 2011-12-31618,369USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2012-07-01 to 2012-09-306,208USD92
2012-01-01 to 2012-09-3018,624USD274
2011-07-01 to 2011-09-306,208USD92
2011-01-01 to 2011-09-3016,664USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2012-01-01 to 2012-09-30218,579USD274
2005-11-29 to 2012-09-30456,206USD2498
2011-01-01 to 2011-09-30101,599USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2012-07-01 to 2012-09-3010,869,816USD92
2012-01-01 to 2012-09-3021,436,348USD274
2005-11-29 to 2012-09-30-9,245,095USD2498
2011-07-01 to 2011-09-305,280,369USD92
2011-01-01 to 2011-09-306,560,224USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2012-01-01 to 2012-09-3022,727USD274
2005-11-29 to 2012-09-30128,319USD2498
2011-01-01 to 2011-09-305,077USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2012-01-01 to 2012-09-3019,124,042USD274
2005-11-29 to 2012-09-3033,546,137USD2498
2012-02-01 to 2012-02-2820,000,000USD28
2011-01-01 to 2011-09-3010,434USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-09-30574,072USD274
2005-11-29 to 2012-09-301,141,267USD2498
2011-01-01 to 2011-09-30216,862USD273

Inspect the source

Entity
INVIVO THERAPEUTICS HOLDINGS CORP. / CIK 0001292519
Captured
SEC response SHA-256
e5ef5d92c1b3dbb01ecea1d495941133d151b2802447d9492e239939c94b9e1b

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001292519.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))